For Big Pharma, the triumph of developing a new lifesaving blockbuster drug that generates billions in revenue is inevitably ...

A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new ...

Unprecedented surge in Irish exports this year was almost entirely driven by shipments of drug ingredients for Eli Lilly ...

Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The clock is up on Biogen’s extra two years of a biosimilar-free U.S. market for its blockbuster multiple sclerosis (MS) med ...

Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.

This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of ...

The FDA approved a new injected version of the cancer immunotherapy drug Keytruda. With injections, patients need only an hour total for treatment, while Keytruda infusion may require two hours.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday. "Until now, neither of these ...

The recent jump in Irish exports was driven almost entirely by pharmaceutical giant Eli Lilly and its two bestselling ...